Jazz Pharmaceuticals JAZZ
NASDAQ JAZZ
$233.01 +1.49 (+0.64%)
At close: Oct 1, 2026 · 4:00 PM EDT

Jazz Pharmaceuticals (JAZZ) Liabilities and Shareholders Equity (2010 - 2026)

Updated

Jazz Pharmaceuticals' Liabilities and Shareholders Equity was $11.08 billion in Q2 2026, up 1.2% from $10.94 billion a year earlier but down 6.6% from the prior quarter.

Analysis

Jazz Pharmaceuticals (JAZZ) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

At the end of FY2025, Liabilities and Shareholders Equity at Jazz Pharmaceuticals came in at $11.66 billion, down 2.9% from FY2024.

  • Liabilities and Shareholders Equity shows a five-year compound annual growth rate of 12.3% (FY2020 to FY2025).
  • In earlier years, Liabilities and Shareholders Equity was $12.01 billion in FY2024 (+5.4%), $11.39 billion in FY2023 (+5.2%), $10.84 billion in FY2022 (-11.9%) and $12.3 billion in FY2021 (+88.2%).
  • Quarterly Liabilities and Shareholders Equity has moved between $10.38 billion (Q3 2022) and $12.48 billion (Q3 2021) over five years.
  • Compared with a year earlier, Liabilities and Shareholders Equity was higher in five of the last eight quarters, with growth averaging 0.8%.
  • The best year-over-year quarter for Liabilities and Shareholders Equity over five years was Q3 2021 (growth of 98.3%); the worst was Q3 2022 (a decline of 16.8%).
  • Per Business Quant data, JAZZ's Liabilities and Shareholders Equity in the three quarters before Q2 2026 was $11.86 billion (Q1 2026), $11.66 billion (Q4 2025) and $11.36 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Jazz Pharmaceuticals 15.03 Bn 8.85 Bn 1.09 Bn 11.08 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.08 Bn
Mar 31, 2026 11.86 Bn
Dec 31, 2025 11.66 Bn
Sep 30, 2025 11.36 Bn
Jun 30, 2025 10.94 Bn
Mar 31, 2025 11.53 Bn
Dec 31, 2024 12.01 Bn
Sep 30, 2024 12.26 Bn
Jun 30, 2024 11.36 Bn
Mar 31, 2024 11.33 Bn
Dec 31, 2023 11.39 Bn
Sep 30, 2023 11.20 Bn
Jun 30, 2023 11.26 Bn
Mar 31, 2023 11.05 Bn
Dec 31, 2022 10.84 Bn
Sep 30, 2022 10.38 Bn
Jun 30, 2022 11.20 Bn
Mar 31, 2022 11.77 Bn
Dec 31, 2021 12.30 Bn
Sep 30, 2021 12.48 Bn
API Access

Jazz Pharmaceuticals Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=JAZZ&period=max&api_key=YOUR_API_KEY